Roller coaster ride: The headquarters of Valeant Pharmaceuticals International Inc in Laval, Quebec. Valeant shares went from a high of US262 to a low of US24 in a matter of 10 months. – Reuters
VALEANT Pharmaceuticals has taken investors on a wild ride.
The drugmaker’s stock price climbed tenfold, to a high of US$262 a share last August, before cratering to about US$24 on June 8, bringing billions of dollars of losses to investors including storied hedge funders Bill Ackman and John Paulson.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
